Greenline Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $492K | Hold |
1,955
| – | – | 0.05% | 129 |
|
|
2026
Q1 | $425K | Sell |
1,955
-30
| -2% | -$6.66K | 0.05% | 129 |
|
|
2025
Q4 | $454K | Buy |
1,985
+30
| +2% | +$6.83K | 0.05% | 126 |
|
|
2025
Q3 | $453K | Buy |
+1,955
| New | +$398K | 0.06% | 121 |
|
|
2025
Q2 | – | Sell |
-1,955
| Closed | -$410K | – | 146 |
|
|
2025
Q1 | $410K | Buy |
1,955
+50
| +3% | +$9.72K | 0.06% | 116 |
|
|
2024
Q4 | $339K | Hold |
1,905
| – | – | 0.05% | 121 |
|
|
2024
Q3 | $376K | Hold |
1,905
| – | – | 0.05% | 122 |
|
|
2024
Q2 | $325K | Sell |
1,905
-50
| -3% | -$8.28K | 0.05% | 116 |
|
|
2024
Q1 | $356K | Hold |
1,955
| – | – | 0.06% | 106 |
|
|
2023
Q4 | $303K | Buy |
1,955
+50
| +3% | +$7.29K | 0.05% | 109 |
|
|
2023
Q3 | $284K | Hold |
1,905
| – | – | 0.05% | 104 |
|
|
2023
Q2 | $257K | Hold |
1,905
| – | – | 0.05% | 108 |
|
|
2023
Q1 | $304K | Hold |
1,905
| – | – | 0.06% | 114 |
|
|
2022
Q4 | $308K | Buy |
1,905
+162
| +9% | +$24.8K | 0.06% | 117 |
|
|
2022
Q3 | $234K | Hold |
1,743
| – | – | 0.05% | 110 |
|
|
2022
Q2 | $267K | Hold |
1,743
| – | – | 0.06% | 107 |
|
|
2022
Q1 | $283K | Hold |
1,743
| – | – | 0.05% | 106 |
|
|
2021
Q4 | $236K | Buy |
+1,743
| New | +$206K | 0.04% | 116 |
|
|
2020
Q2 | – | Sell |
-13,477
| Closed | -$1.03M | – | 109 |
|
|
2020
Q1 | $1.03M | Sell |
13,477
-12,546
| -48% | -$1.07M | 0.33% | 68 |
|
|
2019
Q4 | $2.3M | Sell |
26,023
-8,840
| -25% | -$734K | 0.58% | 51 |
|
|
2019
Q3 | $2.64M | Buy |
34,863
+3,115
| +10% | +$214K | 0.76% | 44 |
|
|
2019
Q2 | $2.31M | Sell |
31,748
-3,168
| -9% | -$249K | 0.73% | 42 |
|
|
2019
Q1 | $2.81M | Sell |
34,916
-6,089
| -15% | -$498K | 0.92% | 41 |
|
|
2018
Q4 | $3.87M | Hold |
41,005
| – | – | 1.21% | 32 |
|
|
2018
Q3 | $3.87M | Buy |
41,005
+1,245
| +3% | +$118K | 1.21% | 32 |
|
|
2018
Q2 | $3.68M | Buy |
39,760
+15,916
| +67% | +$1.55M | 1.21% | 31 |
|
|
2018
Q1 | $2.26M | Buy |
23,844
+15,244
| +177% | +$1.67M | 0.75% | 38 |
|
|
2017
Q4 | $832K | Buy |
+8,600
| New | +$811K | 0.28% | 54 |
|
Other funds holding ABBV
Greenline Partners's ABBV Position: Q2 2026 in Review
Greenline Partners held its AbbVie (ABBV) position steady in Q2 2026 at 1,955 shares worth $492K. The position accounts for 0.05% of the portfolio, ranked #129.
Greenline Partners first reported a position in ABBV in Q4 2017 and has held it in 28 quarters since. The position peaked at $3.87M in Q4 2018. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Greenline Partners held 1,955 shares of AbbVie worth $492K as of Q2 2026.
- Greenline Partners left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.05% of Greenline Partners's portfolio in Q2 2026, its #129 holding.
- Greenline Partners first reported a position in AbbVie in Q4 2017 and has held it in 28 quarters since.
- Greenline Partners's AbbVie position peaked at $3.87M in Q4 2018.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Greenline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.